Search
for
Sort by
Research 601–630 of 1000+
- Understanding the Intricate Pathophysiology of Psoriasis and Related Skin Disorders
- Alopecia Areata Is Associated with an Increased Risk for Prediabetes and Obesity: A Nationwide Case—Control Study
- Unveiling the Effect of Age and IgE Level on Alopecia Areata: Insights from Comparative RNAseq Analysis
- Immunological Abnormalities In PCOS
- The Role of Extracellular Vesicles in the Development and Treatment of Psoriasis: Narrative Review
- Uncommon Presentation of Pityriasis Rubra Pilaris of the Scalp: Clinical, Trichoscopic, and Histopathologic Features and Review of the Literature
- Intranasal sensitization model of alopecia areata using pertussis toxin as adjuvant
- Mesenchymal Stem Cell Therapy in Alopecia Areata: Visual and Molecular Evidence from a Mouse Model
- The vitamin B5/coenzyme A axis: A target for immunomodulation?
- Pharmacotherapy for Keloids and Hypertrophic Scars
- Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences
- Unlocking the versatile potential: Adipose-derived mesenchymal stem cells in ocular surface reconstruction and oculoplastics
- Understanding Type 3 Innate Lymphoid Cells and Crosstalk with the Microbiota: A Skin Connection
- Th22 is the effector cell of thymosin β15-induced hair regeneration in mice
- Justicia procumbens prevents hair loss in androgenic alopecia mice
- Exosomal microRNA-Based therapies for skin diseases
- E-Poster
- Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders
- Nanotechnology-based techniques for hair follicle regeneration
- Cardiovascular risk in patients with scarring and nonscarring alopecias: Assessing the current state of evidence
- Revolutionizing Radiotoxicity Management with Mesenchymal Stem Cells and Their Derivatives: A Focus on Radiation-Induced Cystitis
- Oral Combination Treatment of Gefitinib (IressaTM) and Sasam-Kyeongokgo: Synergistic Effects on the NCI-H520 Tumor Cell Line
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Alopecia Areata in Latin America: Where are We and Where are We Going?
- Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- Genetics of Diabetes in Childhood
- The Association of Serum Adipokines, Insulin Resistance and Vitamin D Status in Male Patients with Androgenetic Alopecia
- Activating an adaptive immune response from a hydrogel scaffold imparts regenerative wound healing
- p63 regulates <i>Satb1</i> to control tissue-specific chromatin remodeling during development of the epidermis